Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
Authors:
Open Access
- 25 November 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12
Abstract
Anti-laminin 332 mucous membrane pemphigoid (MMP) is an autoimmune blistering disease characterized by predominant mucosal lesions and autoantibodies against laminin 332. The exact diagnosis of anti-laminin 332 MMP is important since nearly 30% of patients develop solid cancers. This study compared two independently developed diagnostic indirect immunofluorescence (IF) tests based on recombinant laminin 332 expressed in HEK239 cells (biochip mosaic assay) and the migration trails of cultured keratinocytes rich in laminin 332 (footprint assay). The sera of 54 anti-laminin 332 MMP, 35 non-anti-laminin 332 MMP, and 30 pemphigus vulgaris patients as well as 20 healthy blood donors were analyzed blindly and independently. Fifty-two of 54 and 54/54 anti-laminin 332 MMP sera were positive in the biochip mosaic and the footprint assay, respectively. In the 35 non-anti-laminin 332 MMP sera, 3 were positive in both tests and 4 others showed weak reactivity in the footprint assay. In conclusion, both assays are easy to perform, highly sensitive, and specific, which will further facilitate the diagnosis of anti-laminin 332 MMP.Keywords
This publication has 32 references indexed in Scilit:
- Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoidBritish Journal of Dermatology, 2010
- A case of mucous membrane pemphigoid with IgG antibodies against all the α3, β3 and γ2 subunits of laminin-332 and BP180 C-terminal domain, associated with pancreatic cancerClinical and Experimental Dermatology, 2009
- Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatosesBritish Journal of Dermatology, 2009
- IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoidJournal of the American Academy of Dermatology, 2008
- Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severityBritish Journal of Dermatology, 2005
- Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoidJournal of the American Academy of Dermatology, 2004
- IgG Autoantibodies in Patients with Anti-Epiligrin Cicatricial Pemphigoid Recognize the G Domain of the Laminin 5 α-SubunitClinical Immunology, 2001
- Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (α3β3γ2)British Journal of Dermatology, 1998
- The use of skin substrates deficient in basement membrane (BM) molecules for the diagnosis of subepidermal autoimmune bullous diseasesJournal of Dermatological Science, 1998
- Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease.Journal of Clinical Investigation, 1992